Effect of chronic cytokine therapy on clonal dynamics in nonhuman primates

Blood

Volumn 103, Issue 11, 2004, Pages 4070-4077

  Kuramoto, Ken ^b   Follmann, Dean A ^b   Hematti, Peiman ^b   Sellers, Stephanie ^b   Agricola, Brian A ^b   Metzger, Mark E ^b   Donahue, Robert E ^b   Von Kalle, Christof ^b   Dunbar, Cynthia E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT CYTOKINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEM CELL FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CELL ACTIVITY; CELL CLONE; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CIRCULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RESEARCH; DRUG SCREENING; EVIDENCE BASED MEDICINE; GENE INSERTION; GRANULOCYTE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IN VIVO STUDY; LONG TERM CARE; MOLECULAR DYNAMICS; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RETROVIRUS; RHESUS MONKEY;

EID: 2542452856     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-08-2934     Document Type: Article

References (45)

1. Anderlini P, Körbling M, Dale D, et al. Allogeneic blood stem cell transplantation: considerations for donors. Blood. 1997;90:903-908.
2. Volk EE, Domen RE, Smith ML. An examination of ethical issues raised in the pretreatment of normal volunteer granulocyte donors with granulocyte colony-stimulating factor. Arch Pathol Lab Med. 1999;123:508-513.
3. Cavallaro AM, Ulleby K, Majolino I, et al. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant. 2000;25:85-89.
4. Stroncek DF, Clay ME, Herr G, Smith J, Ilstrup S, McCullough J. Blood counts in healthy donors 1 year after the collection of granulocyte-colony-stimulating factor-mobilized progenitor cells and the results of a second mobilization and collection. Transfusion. 1997;37:304-308.
5. Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood. 1991;78:2791-2808.
6. Metcalf D. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood. 1986;67:257-267.
7. Crawford J, Ozer H, Stoller R, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med. 1991;325:164-170.
8. De Witte T, Gratwohl A, Van Der LN, et al. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantation. Blood. 1992;79:1359-1365.
9. Hartmann LC, Tschetter LK, Habermann TM, et al. Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. N Engl J Med. 1997;336:1776-1780.
10. Kostmann R. Infantile genetic agranulocytosis: a new recessive lethal disease in man. Acta Paediatr Scand. 1956;45:1-368.
11. Bonilla MA, Gillio AP, Ruggeiro M, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med. 1989;320:1574-1580.
12. Freedman MH, Bonilla MA, Fier C, et al. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood. 2000;96:429-436.
13. Dale DC, Cottle TE, Fier CJ, et al. Severe chronic neutropenla: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol. 2003;72:82-93.
14. Kojima S, Ohara A, Tsuchida M, et al. Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood. 2002;100:786-790.
15. Kalra R, Dale D, Freedman M, et al. Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia. Blood. 1995;86:4579-4586.
16. Dong F, Hoefsloot LH, Schelen AM, et al. Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia. Proc Natl Acad Sci U S A. 1994;91:4480-4484.
17. Dong F, Brynes RK, Tidow N, Welte K, Lowenberg B, Touw IP. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med. 1995;333:487-493.
18. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the hematopoietic stem cell niche. Nature. 2003;425:841-846.
19. Kokai Y, Wada T, Oda T, et al. Overexpression of granulocyte colony-stimulating factor induces severe osteopenia in developing mice that is partially prevented by a diet containing vitamin K2 (metatetrenon). Bone. 2002;30:880-885.
20. Yakisan E, Schirg E, Zeidler C, et al. High incidence of significant bone loss in patients with severe congenital neutropenia (Kostmann's syndrome). J Pediatr. 1997;131:592-597.
21. Brandt J, Briddell RA, Srour EF, Leemhuis TB, Hoffman R. Role of c-kit ligand in the expansion of human hematopoietic progenitor cells. Blood. 1992;79:634-641.
22. Broudy VC. Stem cell factor and hematopoiesis. Blood. 1997;90:1345-1364.
23. Bodine DM, Seidel NE, Orlic D. Bone marrow collected 14 days after in vivo administration of granulocyte colony stimulating factor (G-CSF) and stem cell factor(SCF) to mice has 10 fold more repopulating ability than untreated bone marrow. Blood. 1996;88:89-97.
24. Begley CG, Basser R, Mansfield R, et al. Enhanced levels and enhanced clonogenic: capacity of blood progenitor cells following administration of stem cell factor plus granulocyte colony-stimulating factor to humans. Blood. 1997;90:3378-3389.
25. McKinstry WJ, Li CL, Rasko JEJ, Nicola NA, Johnson GR, Metcalf D. Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood. 1997;89:65-71.
26. Abkowitz JL, Fialkow PJ, Niebrugge DJ, Raskind WH, Adamson JW. Pancytopenia as a clonal disorder of a multipotent hematopoietic stem cell. J Clin Invest. 1984;73:258-261.
27. Abkowitz JL, Catlin SN, Guttorp P. Evidence that hematopoiesis may be a stochastic process in vivo. Nat Med. 1996;2:190-196.
28. Guenechea G, Gan OI, Dorrell C, Dick JE. Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat Immunol. 2001;2:75-82.
29. Jordan CT, Lemischka IR. Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev. 1990;4:220-232.
30. Lemischka IR, Jordan CT. The return of clonal marking sheds new light on human hematopoietic stem cells. Nat Immunol. 2001;2:11-12.
31. Schmidt M, Hoffmann G, Wissler M, et al. Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples. Hum Gene Ther. 2001;12:743-749.
32. Schmidt M, Zickler P, Hoffmann G, et al. Polyclonal long-term repopulating stem cell clones in a primate model. Blood. 2002;100:2737-2743.
33. Kim HJ, Tisdale JF, Wu T, et al. Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates. Blood. 2000;96:1-8.
34. Hematti P, Sellers SE, Agricola BA, Metzger ME, Donahue RE, Dunbar CE. Retroviral transduction efficiency of G-CSF+ SCF-mobilized peripheral blood CD34+ cells is superior to G-CSF or G-CSF+ Flt3-L-mobilized cells in nonhuman primates. Blood. 2003;101:2199-2205.
35. Wu T, Kim HJ, Sellers SE, et al. Prolonged high-level detection of retrovirally-marked hematopoietic cells in non-human primates after transduction of CD34+ progenitors using clinically feasible methods. Mol Ther. 2000;1:285-293.
36. Takatoku M, Sellers S, Agricola BA, et al. Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates. J Clin Invest. 2001;108:447-455.
37. Andrews RG, Briddell RA, Knitter GH, Rowley SD, Appelbaum FR, McNiece IK. Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates. Blood. 1995;85:15-20.
38. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCJD-X1. Science. 2003;302:415-419.
39. Klem HP, Sellers S, Thomasson B, et al. Large animals receiving retrovirally transduced stem and progenitor cells do not develop clonal hematopoiesis or leukemia. Mol Ther. 2004;9:389-395.
40. Cheshier SH, Morrison SJ, Liao X, Weissman IL. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc Natl Acad Sci U S A. 1999;96:3120-3125.
41. Mahmud N, Devine SM, Weller KP, et al. The relative quiescence of hematopoietic stem cells in nonhuman primates. Blood. 2001;97:3061-3068.
42. Szyper-Kravitz M, Uziel O, Shapiro H, et al. 2003. Granulocyte colony-stimulating factor administration upregulates telomerase activity in CD34+ haematopoietic cells and may prevent telomere attrition after chemotherapy. Br J Haematol. 2003;120:329-336.
43. Abkowitz JL, Golinelli D, Harrison DE, Guttorp P. In vivo kinetics of murine hemopoietic stem cells. Blood, 2000;96:3399-3405.
44. MacKey MC. Cell kinetic status of haematopoietic stem cells. Cell Prolif. 2001;34:71-83.
45. Abkowitz JL, Robinson AE, Kale S, Long MW, Chen J. Mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure. Blood. 2003;102:1249-1253.